This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bright and colleagues¹ reported an increase in adamantane-resistant influenza A viruses in the United States: less than 2% before 2002, 14.5% from October 2004 through March 2005, and 92.3% from October 1 to December 31, 2005. The authors commented that exposure to amantadine and rimantadine did not seem to explain the increased resistance, because only a minority of the samples was from nursing home settings in which the medications are most likely used. However, the viral resistance may be associated with the recent wide-scale use of another adamantane compound, memantine.

Memantine is a derivative of amantadine with 2 methyl side groups that increase its affinity and dwell time in the N-methyl-D-aspartate–sensitive glutamate receptor channel.² In late 2003, memantine was approved by the US Food and Drug Administration for the treatment of symptoms in moderate to severe Alzheimer disease. After being launched in the . . . [Full Text of this Article]

Raj C. Shah, MD
raj_c_shah@rush.edu
Department of Family Medicine
Rush University Medical Center
Chicago, Ill

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Shift Shown in Influenza A Adamantane Resistance
Katherine M. Shea
JAMA. 2006;296(13):1585.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David K. Shay, Rick A. Bright, Michael Shaw, Nancy J. Cox, and Alexander I. Klimov
JAMA. 2006;296(13):1586-1587.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David M. Weinstock and Gianna Zucotti
JAMA. 2006;296(13):1587.
EXTRACT | FULL TEXT  

Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
Rick A. Bright, David K. Shay, Bo Shu, Nancy J. Cox, and Alexander I. Klimov
JAMA. 2006;295(8):891-894.
ABSTRACT | FULL TEXT  

Adamantane Resistance in Influenza A
David M. Weinstock and Gianna Zuccotti
JAMA. 2006;295(8):934-936.
EXTRACT | FULL TEXT